Rare diseases
Investigational molecules
Locations
Back to Denmark184 clinical trials in Vejle, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer
DenmarkDenmarkStudy on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors
DenmarkStudy Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments
DenmarkStudy of Diclofenac compared to Placebo for Pain Relief in Adults with Knee Osteoarthritis
DenmarkStudy of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer
DenmarkStudy on Trastuzumab Deruxtecan for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
DenmarkStudy Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
DenmarkStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
DenmarkStudy on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
DenmarkStudy Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions
DenmarkStudy of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on advanced treatments for various cancer types, particularly metastatic prostate cancer, chronic lymphocytic leukemia, and colorectal cancer. Studies are evaluating innovative therapies and treatment combinations.
Research emphasizes personalized treatment approaches and novel drug combinations to improve patient outcomes.
Investigations into treatments for chronic inflammatory conditions, including rhinosinusitis, psoriatic arthritis, and inflammatory bowel diseases. Studies are evaluating biologic therapies and their optimal usage.
Focus on developing targeted therapies and understanding treatment duration optimization.
Research into respiratory conditions, particularly focusing on severe asthma and viral lung infections. Studies are examining new therapeutic approaches and treatment effectiveness.
Emphasis on developing innovative treatments for patients with difficult-to-control respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
